Identification of CEBPA familial AML is necessary for appropriate treatment planning and has additional implications for familial testing and screening. Clinical practice is still evolving treatment paradigms for these patients and their families. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Rakiewicz et al. (Wed,) studied this question.